Nature Medicine

Journal Abbreviation: NAT MED
ISSN: 1078-8956
Publisher: Nature Publishing Group

Publications (42)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

A prognostic neural epigenetic signature in high-grade glioma (2024) Drexler R, Khatri R, Sauvigny T, Mohme M, Maire CL, Ryba A, Zghaibeh Y, et al. Journal article Bispecific T cell engager therapy for refractory rheumatoid arthritis (2024) Bucci L, Hagen M, Rothe T, Raimondo MG, Fagni F, Tur C, Wirsching A, et al. Journal article Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial (2024) Pan KF, Li WQ, Zhang L, Liu WD, Ma JL, Zhang Y, Ulm K, et al. Journal article Cranioencephalic functional lymphoid units in glioblastoma (2024) Dobersalske C, Rauschenbach L, Hua Y, Berliner C, Steinbach A, Grüneboom A, Kokkaliaris KD, et al. Journal article Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial (2024) Mann JF, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, Charytan DM, et al. Journal article Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial (2024) Colhoun HM, Lingvay I, Brown PM, Deanfield J, Brown-Frandsen K, Kahn SE, Plutzky J, et al. Journal article Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer (2023) Foersch S, Glasner C, Woerl AC, Eckstein M, Wagner DC, Schulz S, Kellers F, et al. Journal article Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. (2023) Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, Völkl S, et al. Journal article, Erratum Multiomic spatial landscape of innate immune cells at human central nervous system borders (2023) Sankowski R, Süß P, Benkendorff A, Böttcher C, Fernandez-Zapata C, Chhatbar C, Cahueau J, et al. Journal article CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial (2023) Mackensen A, Haanen JB, Koenecke C, Alsdorf W, Wagner-Drouet E, Borchmann P, Heudobler D, et al. Journal article